Inovio Pharmaceuticals Inc (INO)
10.99
-0.04
(-0.36%)
USD |
NASDAQ |
Apr 15, 16:00
8.25
-2.74
(-24.93%)
After-Hours: 20:00
Inovio Pharmaceuticals Enterprise Value: 129.25M for April 12, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 12, 2024 | 129.25M |
| April 11, 2024 | 146.31M |
| April 10, 2024 | 140.47M |
| April 09, 2024 | 143.27M |
| April 08, 2024 | 136.50M |
| April 05, 2024 | 147.13M |
| April 04, 2024 | 150.75M |
| April 03, 2024 | 159.87M |
| April 02, 2024 | 161.50M |
| April 01, 2024 | 178.10M |
| March 28, 2024 | 195.86M |
| March 27, 2024 | 175.99M |
| March 26, 2024 | 160.80M |
| March 25, 2024 | 161.27M |
| March 22, 2024 | 143.04M |
| March 21, 2024 | 128.08M |
| March 20, 2024 | 123.64M |
| March 19, 2024 | 121.07M |
| March 18, 2024 | 122.01M |
| March 15, 2024 | 122.36M |
| March 14, 2024 | 124.11M |
| March 13, 2024 | 134.39M |
| March 12, 2024 | 140.47M |
| March 11, 2024 | 152.86M |
| March 08, 2024 | 109.39M |
| Date | Value |
|---|---|
| March 07, 2024 | 82.51M |
| March 06, 2024 | 102.14M |
| March 05, 2024 | 97.70M |
| March 04, 2024 | 100.97M |
| March 01, 2024 | 94.66M |
| February 29, 2024 | 73.03M |
| February 28, 2024 | 63.93M |
| February 27, 2024 | 76.67M |
| February 26, 2024 | 57.11M |
| February 23, 2024 | 50.62M |
| February 22, 2024 | 45.73M |
| February 21, 2024 | 50.97M |
| February 20, 2024 | 57.34M |
| February 16, 2024 | 51.88M |
| February 15, 2024 | 40.73M |
| February 14, 2024 | 38.45M |
| February 13, 2024 | 20.03M |
| February 12, 2024 | 33.45M |
| February 09, 2024 | 24.80M |
| February 08, 2024 | 2.056M |
| February 07, 2024 | -8.181M |
| February 06, 2024 | -7.954M |
| February 05, 2024 | -17.05M |
| February 02, 2024 | -13.87M |
| February 01, 2024 | -7.726M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-105.65M
Minimum
Jun 28 2023
4.820B
Maximum
Jun 29 2020
688.99M
Average
281.92M
Median
Aug 11 2022
Enterprise Value Benchmarks
| Cerus Corp | 331.98M |
| Stereotaxis Inc | 208.33M |
| Viemed Healthcare Inc | 310.49M |
| AIM ImmunoTech Inc | 15.66M |
| Protalix BioTherapeutics Inc | 61.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.00M |
| Revenue (Quarterly) | 0.1027M |
| Total Expenses (Quarterly) | 27.50M |
| EPS Diluted (Quarterly) | -1.05 |
| Profit Margin (Quarterly) | -24.36K% |
| Earnings Yield | -55.62% |
| Normalized Earnings Yield | -53.76 |